Finance Forum Committee


To build relationships between and among financial professionals throughout the BioNJ Membership and the NJ life sciences ecosystem, foster an educational and professional community, share information and best practices and create peer to peer collaboration to facilitate scientific and medical advancement through financial stewardship. Committee members plan and host meaningful and interactive forums on a variety of topics.

Committee Members

ADMA Biologics, Inc. – Brian Lenz, CPA, Executive Vice President & CFO
EisnerAmper LLP – John Pennett, CPA, Partner-in-Charge, National Life Sciences & Technology Group

Adiso Therapeutics – Scott Megaffin, CEO
Cresa – Michael Epstein, Senior Vice President
Deloitte – Eric Benson, Senior Manager
Deloitte – Alfredo Sakar, Senior Manager
EY – Jared Santisi, Senior Manager, Assurance Services
EY – Joel Wagner, CPA, Senior Manager
Genmab – Anthony Pagano, MBA, MSc, Executive Vice President & CFO
Hepion Pharmaceuticals, Inc. – John Cavan, MBA, MSc, CFO
Insmed – Sara Bonstein, MBA, Chief Financial Officer
IVERIC Bio, Inc.
– Dave Carroll, CFO
Janssen Global R&D – Jose Azevedo Vice President of Finance, CFO
Matinas Biopharma Holdings, Inc.
– Keith Kucinski, CPA, CFO
PricewaterhouseCoopers LLP – Michael Bey, MBA, Partner
PricewaterhouseCoopers LLP – Chris Pierce, CPA, Partner
RSM – Adam Marshall, Director
Signum Biosciences, Inc. – Michael Losch, MBA, CFO